GlycoGenesys GLGS (formerly SafeScience SAFS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GlycoGenesys GLGS (formerly SafeScience SAFS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (9)	2/3/2004 8:33:40 PM
From: tuck	Read Replies (1) of 56

>>BOSTON--(BUSINESS WIRE)--Feb. 3, 2004--GlycoGenesys, Inc. (NASDAQ:GLGS - News), a biotechnology company developing novel drug candidates primarily based on glycobiology, announced that it received today a complaint from David Platt, its former CEO and Chairman alleging breach of his termination agreement with the Company and breach of fiduciary duties, among other claims. The Company believes the lawsuit is frivolous and wholly without merit. It intends to vigorously defend this suit and pursue all legal options against Dr. Platt. << snip Elan sells, Platt sues, maybe a bottom coming? Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next